comparemela.com

Latest Breaking News On - Novartis news - Page 1 : comparemela.com

Abbvie executive Patrick Horber appointed as Novartis s President, International

Basel: Novartis has announced that Marie-France Tschudin, President, Innovative Medicines International and Chief Commercial Officer, has decided to leave the company and will step down from the.

Patrick horberUniversity of zurichGlobal commercial developmentFrance tschudinSenior vice presidentImmunology business unitGlobal strategyGlobal commercialNovartis newsMarie france tschudinVas narasimhan

Novartis gets positive CHMP opinion for Cosentyx in adults with hidradenitis suppurativa

Cosentyx is the first and only fully human biologic that directly inhibits interleukin-17A, an important cytokine involved in the inflammation of psoriatic arthritis, moderate to severe plaque.

Barry mcgrathStaedtisches klinikum dessauNovartis innovative medicines internationalEuropean commissionDrug administrationEuropean hidradenitis suppurativa foundationBrandenburg medical schoolProfessor christosFounding professorHidradenitis suppurativa clinical responseMarie france tschudinChief commercialNovartis newsHidradenitis suppurativaProfessor christosc zouboulisDr barry mcgrath

Novartis gets positive EMA panel opinion for prostate cancer drug Pluvicto

Pluvicto is a radioligand therapy combining a targeting compound (ligand, in this case directed to PSMA) with a therapeutic radioisotope

France generalKarim fizaziGustave roussyInnovative medicines internationalEuropean commissionMedical oncologyMarie france tschudinChief commercial officerNorthern irelandNovartis newsAndrogen deprivation therapyProstate cancerProf karim fizazi

US Supreme Court turns down Novartis bid to block launch of multiple sclerosis drug Gilenya generics

Novartis settled with some of the drugmakers it had sued, allowing for some Gilenya generics before a key patent s 2027 expiration.

United statesJustice john robertsAurobindo pharma ltdUs courtDrug administrationUs supreme court onSun pharmaceutical industries ltdSupreme courtViatris inc mylan pharmaceuticalsApotex incPharm co ltdIndia based aurobindo pharma ltdPennsylvania based viatris incMylan pharmaceuticalsCanada based apotexFederal circuit

Novartis to prioritise US market, unfazed by drug pricing pushback

Novartis aspire to "organically build its U.S. business to become a top-five player in the U.S. by 2027," it said in a statement.

United statesJoe bidenHealth careSwiss exchangeInflation reduction actNovartis newsPartd drugsVas narasimhan

vimarsana © 2020. All Rights Reserved.